Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Livermore

Showing results (21-30 of 269) with videos related to

Pageof 27
Sort By:
The Journal of Infection|September 22, 2009
Infections caused by Gram-positive bacteria: a review of the global challengeNeil Woodford, David M Livermore
Infection & Chemotherapy|November 23, 2013
Revolutionising bacteriology to improve treatment outcomes and antibiotic stewardshipDavid M Livermore, John Wain
The Journal of Antimicrobial Chemotherapy|December 17, 2008
Effects of low temperature and high salt on the activity of the novel carbapenem PZ-601 (SMP-601) against methicillin-resistant Staphylococcus aureusDavid M Livermore, Marina Warner
The Journal of Antimicrobial Chemotherapy|April 13, 2013
Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant EnterobacteriaceaeDavid M Livermore, Shazad Mushtaq
Trends in Microbiology|August 1, 2006
The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and AcinetobacterDavid M Livermore, Neil Woodford
The Journal of Antimicrobial Chemotherapy|January 21, 2010
AmpC induction by ceftarolineShazad Mushtaq, David M Livermore
The Journal of Antimicrobial Chemotherapy|December 20, 2008
Temocillin revivedDavid M Livermore, Paul M Tulkens
BMJ (Clinical Research Ed.)|June 2, 2012
Carbapenem antibiotics for serious infectionsPeter M Hawkey, David M Livermore
The Journal of Antimicrobial Chemotherapy|July 3, 2010
Chequerboard titration of cephalosporin CXA-101 (FR264205) and tazobactam versus beta-lactamase-producing EnterobacteriaceaeDavid M Livermore, Shazad Mushtaq, Yigong Ge
Antimicrobial Agents and Chemotherapy|July 27, 2004
Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potentialShazad Mushtaq, Yigong Ge, David M Livermore
Pageof 27

Showing results (21-30 of 269) with videos related to

Sort By:
Pageof 27
The Journal of Infection|September 22, 2009
Infections caused by Gram-positive bacteria: a review of the global challengeNeil Woodford, David M Livermore
Infection & Chemotherapy|November 23, 2013
Revolutionising bacteriology to improve treatment outcomes and antibiotic stewardshipDavid M Livermore, John Wain
The Journal of Antimicrobial Chemotherapy|December 17, 2008
Effects of low temperature and high salt on the activity of the novel carbapenem PZ-601 (SMP-601) against methicillin-resistant Staphylococcus aureusDavid M Livermore, Marina Warner
The Journal of Antimicrobial Chemotherapy|April 13, 2013
Activity of biapenem (RPX2003) combined with the boronate β-lactamase inhibitor RPX7009 against carbapenem-resistant EnterobacteriaceaeDavid M Livermore, Shazad Mushtaq
Trends in Microbiology|August 1, 2006
The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and AcinetobacterDavid M Livermore, Neil Woodford
The Journal of Antimicrobial Chemotherapy|January 21, 2010
AmpC induction by ceftarolineShazad Mushtaq, David M Livermore
The Journal of Antimicrobial Chemotherapy|December 20, 2008
Temocillin revivedDavid M Livermore, Paul M Tulkens
BMJ (Clinical Research Ed.)|June 2, 2012
Carbapenem antibiotics for serious infectionsPeter M Hawkey, David M Livermore
The Journal of Antimicrobial Chemotherapy|July 3, 2010
Chequerboard titration of cephalosporin CXA-101 (FR264205) and tazobactam versus beta-lactamase-producing EnterobacteriaceaeDavid M Livermore, Shazad Mushtaq, Yigong Ge
Antimicrobial Agents and Chemotherapy|July 27, 2004
Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potentialShazad Mushtaq, Yigong Ge, David M Livermore
Pageof 27